A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Cavosonstat Administered Twice Daily Compared With Placebo for 24 Weeks in Adult Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT04600778 · UNKNOWN
Trial details
- NCT number
- NCT04600778
- Sponsor
- GSNOR Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-03
- Primary completion
- 2021-12-31
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.